BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16935791)

  • 1. Investigation of the HLA-DRB1 locus in alopecia areata.
    Entz P; Blaumeiser B; Betz RC; Lambert J; Seymons K; Eigelshoven S; Hanneken S; Kruse R; Nürnberg P; Nagy M; Nöthen MM
    Eur J Dermatol; 2006; 16(4):363-7. PubMed ID: 16935791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protective role of the HLA-DR locus in patients with various clinical types of alopecia areata.
    Broniarczyk-Dyła G; Prusińska-Bratoś M; Dubla-Berner M; Arkuszewska C; Borowiec M; Kowalski ML; Woszczek G
    Arch Immunol Ther Exp (Warsz); 2002; 50(5):333-6. PubMed ID: 12455867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA class II alleles in patients with alopecia areata.
    Akar A; Orkunoglu E; Sengül A; Ozata M; Gür AR
    Eur J Dermatol; 2002; 12(3):236-9. PubMed ID: 11978563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Earlier occurrence of severe alopecia areata in HLA-DRB1*11-positive patients.
    Marques Da Costa C; Dupont E; Van der Cruys M; Andrien M; Hidajat M; Song M; Stene JJ
    Dermatology; 2006; 213(1):12-4. PubMed ID: 16778420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-D locus associations in alopecia areata. DRw52a may confer disease resistance.
    Duvic M; Hordinsky MK; Fiedler VC; O'Brien WR; Young R; Reveille JD
    Arch Dermatol; 1991 Jan; 127(1):64-8. PubMed ID: 1670917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic association of HLA-DQB1 and HLA-DRB1 polymorphisms with alopecia areata in the Italian population.
    Megiorni F; Pizzuti A; Mora B; Rizzuti A; Garelli V; Maxia C; Carlesimo M; Fotruna MC; Delle Chiaie R; Cavaggioni G; Rossi A
    Br J Dermatol; 2011 Oct; 165(4):823-7. PubMed ID: 21692766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA class II antigen associations help to define two types of alopecia areata.
    Colombe BW; Price VH; Khoury EL; Garovoy MR; Lou CD
    J Am Acad Dermatol; 1995 Nov; 33(5 Pt 1):757-64. PubMed ID: 7593774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The study on relation of HLA-DRB1 gene polymorphism to Keshan disease and its association and linkage in the core families].
    Wei J; Niu XL; Dong X; Wang YP; Zhu JH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):91-3. PubMed ID: 17285554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin.
    Martorana D; Vaglio A; Greco P; Zanetti A; Moroni G; Salvarani C; Savi M; Buzio C; Neri TM
    Arthritis Rheum; 2006 Feb; 55(1):126-30. PubMed ID: 16463424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The R620W polymorphism in PTPN22 confers general susceptibility for the development of alopecia areata.
    Betz RC; König K; Flaquer A; Redler S; Eigelshoven S; Kortüm AK; Hanneken S; Hillmer A; Tüting T; Lambert J; De Weert J; Kruse R; Lutz G; Blaumeiser B; Nöthen MM
    Br J Dermatol; 2008 Feb; 158(2):389-91. PubMed ID: 18028494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between beta2 adrenergic receptor polymorphisms and rheumatoid arthritis in conjunction with human leukocyte antigen (HLA)-DRB1 shared epitope.
    Malysheva O; Pierer M; Wagner U; Wahle M; Wagner U; Baerwald CG
    Ann Rheum Dis; 2008 Dec; 67(12):1759-64. PubMed ID: 18267980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-DRB1 alleles in Hb SS patients with avascular necrosis of the femoral head.
    Adekile A; Haider MZ; Marouf R; Adekile AD
    Am J Hematol; 2005 May; 79(1):8-10. PubMed ID: 15849775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modifying effects of HLA-DRB1 allele interactions on age at onset of multiple sclerosis in Western Australia.
    Wu JS; Qiu W; Castley A; James I; Mastaglia FL; Christiansen FT; Carroll WM; Joseph J; Kermode AG
    Mult Scler; 2010 Jan; 16(1):15-20. PubMed ID: 19995849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association of polymorphism on HLA-DRB1*04 alleles with outcome of hepatitis B virus infection].
    Song MS; Li HW; Peng HY; Duan BN; Chen H; Xu LQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):467-9. PubMed ID: 17680546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The TRAF1/C5 locus confers risk for familial and severe alopecia areata.
    Redler S; Brockschmidt FF; Forstbauer L; Giehl KA; Herold C; Eigelshoven S; Hanneken S; De Weert J; Lutz G; Wolff H; Kruse R; Blaumeiser B; Böhm M; Becker T; Nöthen MM; Betz RC
    Br J Dermatol; 2010 Apr; 162(4):866-9. PubMed ID: 20030635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
    Barcellos LF; Sawcer S; Ramsay PP; Baranzini SE; Thomson G; Briggs F; Cree BC; Begovich AB; Villoslada P; Montalban X; Uccelli A; Savettieri G; Lincoln RR; DeLoa C; Haines JL; Pericak-Vance MA; Compston A; Hauser SL; Oksenberg JR
    Hum Mol Genet; 2006 Sep; 15(18):2813-24. PubMed ID: 16905561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
    Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B
    J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association of HLA-DRB1 and -DPB1 allele polymorphism with multiple sclerosis in Chinese Han population from Southern areas].
    Wu XM; Zhang KN; Wang CD; Xiong YQ; Liu Z; Qu XH; Xie XF
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2741-4. PubMed ID: 18167262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DRB1 alleles and Henoch-Schönlein purpura: susceptibility and severity of disease.
    Soylemezoglu O; Peru H; Gonen S; Cetinyurek A; Buyan N
    J Rheumatol; 2008 Jun; 35(6):1165-8. PubMed ID: 18412308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.